Sign In
Buy CVM
$1.22
-0.160 (-11.59%)
At Close: Jul 13, 2026
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI to launch FDA Registration-Enabling Phase 3 Confirmatory Study to bring Multikine to Market for newly diagnosed head and neck cancer.
CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care
08:00am, Wednesday, 24'th Jun 2026
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #BIO2026--CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care.
CEL-SCI Announces Closing of Offering
04:01pm, Tuesday, 16'th Jun 2026
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI announces closing of offering.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI advances Multikine immunotherapy for Head and Neck Cancer through dual U.S. registration study and Saudi market entry strategy.
CEL-SCI Corporation Announces Pricing of Offering
07:03pm, Sunday, 14'th Jun 2026
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Corporation announces pricing of offering.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI and Saudi Amarox to conduct signing ceremony at BIO 2026 for Strategic Agreement to advance commercialization and distribution of Multikine.
CEL-SCI Reports Fiscal Second Quarter 2026 Results
08:00am, Monday, 18'th May 2026
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI reported financial results for three months ended March 31, 2026, as well as key corporate developments for Multikine.
CEL-SCI Announces Closing of Public Offering
03:00pm, Wednesday, 13'th May 2026
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI announces closing of public offering.
CEL-SCI Corporation Announces Pricing of Public Offering
08:11pm, Monday, 11'th May 2026
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Corporation Announces Pricing of Public Offering.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia.
Itaú Unibanco Holding files 2025 Form 20-F with the SEC and the CVM
08:07am, Thursday, 30'th Apr 2026
SÃO PAULO, April 30, 2026 /PRNewswire/ -- Itaú Unibanco Holding S.A. (the "Company") announces to the market that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2
Cel-Sci (NYSEAMERICAN:CVM) Shares Down 0.9% – What’s Next?
02:21am, Friday, 24'th Apr 2026
Cel-Sci Corporation (NYSEAMERICAN:CVM - Get Free Report) was down 0.9% on Thursday. The stock traded as low as $3.27 and last traded at $3.31. Approximately 30,767 shares changed hands during mid-day
Cel-Sci (NYSEAMERICAN:CVM) Stock Price Up 6.9% – Time to Buy?
01:59am, Thursday, 02'nd Apr 2026
Cel-Sci Corporation (NYSEAMERICAN:CVM - Get Free Report)'s stock price shot up 6.9% on Wednesday. The company traded as high as $3.60 and last traded at $3.43. 52,583 shares traded hands during tradin
CEL-SCI Reports Fiscal First Quarter 2026 Results
09:00am, Wednesday, 18'th Feb 2026
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI reported financial results for three months ended December 31, 2025, as well as key recent clinical and corporate developments.
Cel-Sci (NYSEAMERICAN:CVM) Stock Price Down 6.5% – What’s Next?
02:06am, Saturday, 10'th Jan 2026
Cel-Sci Corporation (NYSEAMERICAN:CVM - Get Free Report)'s stock price was down 6.5% during trading on Friday. The stock traded as low as $5.44 and last traded at $5.48. Approximately 58,410 shares tr
